Binder Jet Printing in Pharmaceutical Manufacturing
Binder jet printing is arguably the most successful three-dimensional printing (3DP) technology in the pharmaceutical industry to date. In 2015, the binder jet process was adapted as an alternative mass manufacturing technique to enable the production of Spritam® (the first 3D printed tablet) approved by the Food and Drug Administration (FDA). Binder jet printing is expected to continue making a widespread impact to formulation manufacture over the next decade. In particular, binder jet printing offers benefits of producing oral dosage forms with unique release characteristics ranging from fast-dissolving through to controlled-release platforms. This chapter aims to discuss the history and methodology of binder jet printing, pharmaceutical and medical applications, considerations for formulations development and advantages and disadvantages of such processes in the pharmaceutical space.
Keywords3D printing Additive manufacturing Printing medicines Personalized medications Drug delivery systems Digital healthcare
- 1.Sachs EM, Haggerty J, Cima MJ, Williams PA. InventorsThree-dimensional Printing Techniques. US5204055.1993.Google Scholar
- 2.Aprecia Pharmaceuticals. 3D printing - ZipDose technology. 2015. Available from: https://aprecia.com/zipdose-platform/3d-printing.php.
- 3.Day SP, Shufflebottom L. Evidential value from inkjet printers. Probl Forensic Sci. 2001;XLVI:356–74.Google Scholar
- 9.Alomari M, Mohamed FH, Basit AW, Gaisford S. Personalised dosing: printing a dose of one’s own medicine. Int J Pharm. 2015;494(2):568–77.Google Scholar
- 17.Awad A, Trenfield SJ, Gaisford S, Basit AW. 3D printed medicines: A new branch of digital healthcare. Int J Pharm. 2018;548(1):586–96.Google Scholar
- 35.FDA. Keppra XR (Levetiracetam) extended-release tablets. 2009. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022285s000_TOC.cfm.
- 36.Boudriau S, Hanzel C, Massicotte J, Sayegh L, Wang J, Lefebvre M. Randomized comparative bioavailability of a novel three-dimensional printed fast-melt formulation of Levetiracetam following the Administration of a single 1000-mg dose to healthy human volunteers under fasting and fed conditions. Drugs R&D. 2016;16(2):229–38.CrossRefGoogle Scholar
- 38.Kalaskar D. 3D printing in medicine. 1st ed. Duxford: Woodhead Publishing; 2017.Google Scholar
- 39.Monkhouse D, Kumar S, Rowe C, Yoo J. Rapid prototyping and manufacturing process. 2003. Available from: http://www.google.com/patents/US20030173695.
- 41.Awad A, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. Reshaping drug development using 3D printing. Drug Discov Today. 2018; https://doi.org/10.1016/j.drudis.2018.05.025.
- 43.Vaezi M, Yang S. 2 – Freeform fabrication of nanobiomaterials using 3D printing. Rapid prototyping of biomaterials: Woodhead Publishing; 2014. p. 16–74.Google Scholar